Sterling Capital Management LLC
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1329883
CHARLOTTE, NC
Position in BIO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$160,311
-$12,792 QoQ
Shares Held
546
-12.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#273
of 397 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Sterling Capital Management LLC holds $36,795,425 across 72 Medical Devices names. BIO ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
207,301 | $18,810,492 | |
| 2 | DXCM |
Dexcom Inc
|
84,802 | $5,711,414 | |
| 3 | MDT |
Medtronic plc
|
25,030 | $1,958,096 | |
| 4 | EW |
Edwards Lifesciences Corp
|
17,290 | $1,564,053 | |
| 5 | AORT |
Artivion, Inc.
|
48,906 | $1,098,917 | |
| 6 | PHG |
Koninklijke Philips NV
|
35,788 | $973,075 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
13,807 | $883,786 | |
| 8 | SIBN |
SI-BONE, Inc.
|
44,895 | $732,686 |
All Filings in BIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,311 | 546 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $173,103 | 621 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $331,774 | 1,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $324,411 | 1,157 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $257,686 | 1,058 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $375,815 | 1,144 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $246,250 | 736 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||